GE HealthCare Technologies Inc.SEC Filings
|
|
All SEC filings by GE HealthCare Technologies Inc. (GEHC) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| 10-Q | Quarterly report | View Diff | Jul 29, 2026 | |
| 10-Q | Quarterly report | View Diff | Apr 29, 2026 | |
| ARS | Annual report to shareholders | Mar 19, 2026 | ||
| 10-K | Annual report | View Diff | Feb 4, 2026 | |
| 10-Q | Quarterly report | View Diff | Oct 29, 2025 | |
| 10-Q | Quarterly report | View Diff | Jul 30, 2025 | |
| 10-Q | Quarterly report | View Diff | Apr 30, 2025 | |
| ARS | Annual report to shareholders | Apr 10, 2025 | ||
| 10-K | Annual report | View Diff | Feb 13, 2025 | |
| 10-Q | Quarterly report | View Diff | Oct 30, 2024 |
Events
| 8-K | Ge Healthcare Appoints William Grogan as Chief Financial Officer | Aug 18, 2026 | ||
| 8-K | Recast Unaudited Historical Financial Information Reflecting the Companys New Reportable Segment Structure | Jul 29, 2026 | ||
| 8-K | Ge Healthcare Reports Second Quarter 2026 Financial Results | Jul 29, 2026 | ||
| 8-K | Ge Healthcare Announces Cfo Transition Reports Preliminary Second Quarter 2026 Financial Results and Reaffirms Guidance Reflecting Business Momentum | Jul 23, 2026 | ||
| 8-K | Submission of Matters to a Vote of Security Holders | May 11, 2026 | ||
| 8-K | Ge Healthcare Reports First Quarter 2026 Financial Results | Apr 29, 2026 | ||
| 8-K | Ge Healthcare Appoints Medtech Leader Kevin Lobo to Board of Directors | Mar 17, 2026 | ||
| 8-K | Entry Into a Material Definitive Agreement | Feb 27, 2026 | ||
| 8-K | Results of Operations and Financial Condition | Feb 4, 2026 | ||
| 8-K | Entry Into a Material Definitive Agreement | Dec 15, 2025 |
Registrations and Prospectuses
| 424B2 | Prospectus for primary offering | Dec 2, 2025 | ||
| FWP | Free writing prospectus | Dec 1, 2025 | ||
| 424B2 | Prospectus for primary offering | Dec 1, 2025 | ||
| 424B2 | Prospectus for primary offering | Jun 5, 2025 | ||
| FWP | Free writing prospectus | Jun 3, 2025 | ||
| 424B2 | Prospectus for primary offering | Jun 3, 2025 | ||
| 424B3 | Prospectus supplement | Nov 8, 2024 | ||
| FWP | Free writing prospectus | Nov 7, 2024 | ||
| 424B3 | Prospectus supplement | Sep 13, 2024 | ||
| FWP | Free writing prospectus | Sep 12, 2024 |
Proxies
| DEFA14A | Additional proxy soliciting materials | Mar 19, 2026 | ||
| DEF 14A | Definitive proxy | View Diff | Mar 19, 2026 | |
| DEFA14A | Additional proxy soliciting materials | Apr 10, 2025 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 10, 2025 | |
| DEFA14A | Additional proxy soliciting materials | Apr 4, 2024 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 4, 2024 | |
| DEFA14A | Additional proxy soliciting materials | Apr 5, 2023 | ||
| DEF 14A | Definitive proxy | Apr 5, 2023 |
Other
| SD | Conflict minerals disclosure | May 29, 2026 | ||
| SD | Conflict minerals disclosure | May 29, 2025 | ||
| SD | Conflict minerals disclosure | May 30, 2024 | ||
| EFFECT | Notice of effectiveness | Aug 3, 2023 | ||
| EFFECT | Notice of effectiveness | Jun 8, 2023 | ||
| CORRESP | Correspondence with SEC | Jun 5, 2023 | ||
| CORRESP | Correspondence with SEC | Jun 5, 2023 | ||
| SD | Conflict minerals disclosure | May 31, 2023 | ||
| EFFECT | Notice of effectiveness | May 24, 2023 | ||
| CORRESP | Correspondence with SEC | May 4, 2023 |